Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Wall Street down for second day after rally; healthcare gains

Published 03/04/2015, 04:33 PM
Updated 03/04/2015, 04:33 PM
© Reuters. Traders work on the floor of the New York Stock Exchange

By Sinead Carew

NEW YORK (Reuters) - U.S. stocks closed down on Wednesday for the second day in a row as investors stepped back after a recent rally ahead of jobs data due later in the week.

Healthcare stocks were the only bright spot in the market after a U.S. Supreme Court hearing and a cancer drug approval.

Equities had surged in February and both the Dow and S&P hit record highs on Monday, when the Nasdaq surpassed the 5,000 level for the first time in 15 years.

"We would not read anything into today's pullback. The market had a terrific February," said David Katz, chief investment officer at Matrix Asset Advisors, in New York. "We suggest buying into any weakness."

Many investors were holding off on making big bets ahead of a flurry of economic data due in the rest of the week, culminating with the Labor Department's February payrolls report. The jobs report is viewed as a gauge for the timing of the first Federal Reserve interest rate hike in years.

The S&P 500 healthcare index <.SPXHC>, which has risen 5.75 percent since year-end, finished up 0.39 percent Wednesday as investors bet that the Supreme Court may lean toward the Obama administration's view on the Affordable Care Act after the court heard a second major challenge to the law.

"I think that hearing assuaged fears - at least for now - that we were headed for overturning of Obamacare," said Quincy Krosby, market strategist at Prudential Financial (NYSE:PRU) in Newark, New Jersey.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Bristol Myers Squibb (N:BMY) shares surged 6 percent to $65.67 after U.S. health regulators approved its Opdivo treatment for lung cancer.

HCA Holdings (N:HCA) closed up 5.8 percent at $74.93 and Tenet Healthcare (N:THC) finished up 6.2 percent at $49.99.

The U.S. economy continued to expand across most regions and sectors from early January through mid-February, the Fed said Wednesday afternoon in its Beige Book report.

    The ADP National Employment Report showed private employers added 212,000 jobs in February, short of the 220,000 forecast, although January's reading was revised upward. Readings on the services sector from Markit and the Institute for Supply Management both pointed to modest growth.

The Dow Jones industrial average (DJI) fell 106.47 points, or 0.58 percent, to 18,096.9, the S&P 500 (SPX) lost 9.25 points, or 0.44 percent, to 2,098.53 and the Nasdaq Composite (IXIC) dropped 12.76 points, or 0.26 percent, to 4,967.14.

About 6.34 billion shares changed hands on U.S. exchanges, below the 6.52 billion average for the last five sessions, according to BATS Global Markets.

Declining issues outnumbered advancing ones on the NYSE by 1,869 to 1,170, for a 1.60-to-1 ratio; on the Nasdaq, 1,586 issues fell and 1,118 advanced, for a 1.42-to-1 ratio.

The S&P 500 posted 17 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 79 new highs and 50 new lows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.